54 157 (Montelukast sodium 10 mg (base))
Pill imprint 54 157 has been identified as Montelukast sodium 10 mg (base).
Montelukast is used in the treatment of allergic rhinitis; bronchospasm prophylaxis; asthma, maintenance; asthma; copd and belongs to the drug class leukotriene modifiers. There is no proven risk in humans during pregnancy. Montelukast 10 mg (base) is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).
- 10 mg (base)
- Prescription only
ferric oxide red
ferric oxide yellow
polyethylene glycol 3350
sodium starch glycolate type A potato
More about montelukast
- Other brands: Singulair
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.